Literature DB >> 8548386

Sirolimus (rapamycin) inhibits mitogen-induced stimulation of protein synthesis in primary lymphocytes.

C C Bansbach1, D Wancio, S N Sehgal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548386     DOI: 10.1007/bf01778320

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

Review 1.  Rapamycin: in vitro profile of a new immunosuppressive macrolide.

Authors:  S N Sehgal; C C Bansbach
Journal:  Ann N Y Acad Sci       Date:  1993-06-23       Impact factor: 5.691

2.  Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.

Authors:  C J Kuo; J Chung; D F Fiorentino; W M Flanagan; J Blenis; G R Crabtree
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.

Authors:  H B Jefferies; C Reinhard; S C Kozma; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

4.  Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.

Authors:  N Terada; J J Lucas; A Szepesi; R A Franklin; K Takase; E W Gelfand
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

5.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.

Authors:  D J Price; J R Grove; V Calvo; J Avruch; B E Bierer
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

6.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.

Authors:  J Chung; C J Kuo; G R Crabtree; J Blenis
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

  6 in total
  1 in total

Review 1.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.